JAM
BIIB icon

JW Asset Management’s Biogen BIIB Stock Holding History

JW Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,950
Closed -$2M – 58
2015
Q2 		$2M Sell
4,950
-3,154
-39% -$1.27M 0.61% 26
2015
Q1 		$3.42M Buy
8,104
+4,235
+109% +$1.67M 1.48% 17
2014
Q4 		$1.31M Buy
+3,869
New +$1.25M 0.99% 21

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

JW Asset Management's BIIB Position: Q3 2015 in Review

JW Asset Management sold out of Biogen (BIIB) in Q3 2015, closing a stake of 4,950 shares — an estimated $2M sold.

JW Asset Management first reported a position in BIIB in Q4 2014 and held it in 3 quarters. The position peaked at $3.42M in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • JW Asset Management reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • JW Asset Management sold 4,950 Biogen shares in Q3 2015, an estimated $2M.
  • JW Asset Management first reported a position in Biogen in Q4 2014 and held it in 3 quarters.
  • JW Asset Management's Biogen position peaked at $3.42M in Q1 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on JW Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.